Skip to main content
Grants and Awards Research,
Grayson Mendenhall
December 14, 2005



School of Pharmacy Ranks Seventeenth in NIH Funding

In fiscal year 2004, the School of Pharmacy at the University of North Carolina at Chapel Hill received $5.2 million in funding from the National Institutes of Health, ranking seventeenth among the nation’s pharmacy schools. The School ranked twenty-second in fiscal year 2003.

“The NIH funding we receive is a measure of the excellence of our faculty, of the promise of their ideas, and of their commitment to innovation,” said Dean Robert A. Blouin. “I am extremely proud of these people who are able to so expertly tackle the challenges of both the lab and the classroom.”

Overall, UNC faculty attracted $289.7 million in NIH funding—up 7 percent from $271 million in 2003—ranking fifteenth overall among U.S. private and public universities. Johns Hopkins University topped the list at $599.2 million. UNC is the top public university in the South and one of only six Southern universities, public or private, cited in the NIH’s top twenty.  All five of UNC’s health affairs schools—dentistry, medicine, nursing, pharmacy and public health—ranked within the top twenty of public and private institutions, according to the NIH.

“Across the board, our faculty in the health sciences continue to demonstrate that they are among the best in the nation,” said Tony Waldrop, PhD, vice chancellor for research and economic development at UNC. “Numbers like these are possible because a great many Carolina researchers are working very hard to improve people’s health.” The NIH, part of the U.S. Department of Health and Human Services, is the principal biomedical research arm of the federal government. NIH research institutes are fighting diseases including AIDS, alcoholism, arthritis, cancer, diabetes and stroke, as well as tackling health topics related to aging, women and children, drug abuse, the environment and rapidly emerging multidisciplinary fields such as genomics and proteomics.

Latest News


Comments are closed.